Paul Hastings Advised TD Cowen and Wedbush PacGrow in Connection With Monte Rosa Therapeutics' Underwritten Public Offering
May 17, 2024
May 17, 2024
LOS ANGELES, California, May 17 -- Paul Hastings, a law firm, issued the following news:
Paul Hastings advised TD Cowen and Wedbush PacGrow, as joint book-running managers, in connection with Monte Rosa Therapeutics' (Nasdaq: GLUE) underwritten public offering.
The offering is expected to close on May 20, 2024, subject to satisfaction of customary closing conditions.
More details on the transaction can be found here (https://ir.monterosatx.com/news-releases . . .
Paul Hastings advised TD Cowen and Wedbush PacGrow, as joint book-running managers, in connection with Monte Rosa Therapeutics' (Nasdaq: GLUE) underwritten public offering.
The offering is expected to close on May 20, 2024, subject to satisfaction of customary closing conditions.
More details on the transaction can be found here (https://ir.monterosatx.com/news-releases . . .